Analyst Recommendations

Needham analyst issues BUY recommendation for XRAY on April 18, 2024 10:00AM ET. The previous analyst recommendation was Buy.XRAY was trading at $30.53 at issue of the analyst...

April 18, 2024   XRAY -2.47%

Leerink Partners analyst issues UNDERPERFORM recommendation for XRAY on April 18, 2024 10:00AM ET. The previous analyst recommendation was Underperform.XRAY was trading at $30.53 at issue of the...

April 18, 2024   XRAY -2.47%

Citigroup analyst issues SELL recommendation for XPEV on April 18, 2024 10:26AM ET. The previous analyst recommendation was Sell.XPEV was trading at $7.295 at issue of the analyst...

April 18, 2024   XPEV -0.17%

Citigroup analyst issues BUY recommendation for PCG on April 18, 2024 10:40AM ET. The previous analyst recommendation was Buy.PCG was trading at $16.48 at issue of the analyst...

April 18, 2024   PCG -0.89%

CFRA analyst issues BUY recommendation for GPC on April 18, 2024 10:41AM ET. The previous analyst recommendation was Buy.GPC was trading at $160.361 at issue of the analyst...

April 18, 2024   GPC -1.17%

Oppenheimer analyst issues OUTPERFORM recommendation for NFLX on April 18, 2024 10:33AM ET. The previous analyst recommendation was Outperform.NFLX was trading at $616.87 at issue of the analyst...

April 18, 2024   NFLX -0.44%

Daiwa analyst issues OUTPERFORM recommendation for TSM on April 18, 2024 10:09AM ET. The previous analyst recommendation was Buy.TSM was trading at $135 at issue of the analyst...

April 18, 2024   TSM 0.28%

Citigroup analyst issues NEUTRAL recommendation for FCX on April 18, 2024 10:44AM ET. The previous analyst recommendation was Neutral.FCX was trading at $50.39 at issue of the analyst...

April 18, 2024   FCX -1.80%

Wells Fargo analyst issues OVERWEIGHT recommendation for MU on April 18, 2024 10:51AM ET. The previous analyst recommendation was Overweight.MU was trading at $113.14 at issue of the...

April 18, 2024   MU 1.15%

Keefe, Bruyette & Woods analyst issues OUTPERFORM recommendation for ALL on April 18, 2024 11:00AM ET. The previous analyst recommendation was Outperform.ALL was trading at $168.79 at issue...

April 18, 2024   ALL -0.69%